Results 71 to 80 of about 18,628 (145)

Update on the everolimus-eluting coronary stent system: results and implications from the SPIRIT clinical trial program

Vascular Health and Risk Management, 2009
R Michael Kirchner, J Dawn AbbottDepartment of Cardiology, Rhode Island Hospital, Brown Medical School, Providence, RI, USAAbstract: Drug-eluting stents (DES) have had a major impact in interventional cardiology.
R Michael Kirchner, J Dawn Abbott
doaj  

Two-year Outcome of Turkish Patients Treated with Zotarolimus Versus Paclitaxel Eluting Stents in an Unselected Population with Coronary Artery Disease in the Real World: A Prospective Non-randomized Registry in Southern Turkey

International Journal of Medical Sciences, 2011
Background: Our purpose was to investigate the clinical outcomes of Zotarolimus- and Paclitaxel-eluting stents in Turkish patients with coronary artery disease (CAD).
Davran Çiçek, Hasan Pekdemir, Cevahir Haberal, Nihat Kalay, Süleyman Binici, Hakan Altay, Haldun Müderrisoğlu
doaj  

Promoting vascular healing using nanofibrous ticagrelor-eluting stents

International Journal of Nanomedicine, 2018
Cheng-Hung Lee,1 Ming-Jer Hsieh,1 Kuo-Sheng Liu,2,3 Che-Wei Cheng,3 Shang-Hung Chang,1 Shih-Jung Liu,3,4 Chao-Jan Wang,5 Ming-Yi Hsu,5 Kuo-Chun Hung,1 Yung-Hsin Yeh,1 Wei-Jan Chen,1 I-Chang Hsieh,1 Jyuhn-Huarng Juang,6 Ming-Shien Wen1 1Division of ...
Lee CH, Hsieh MJ, Liu KS, Cheng CW, Chang SH, Liu SJ, Wang CJ, Hsu MY, Hung KC, Yeh YH, Chen WJ, Hsieh IC, Juang JH, Wen MS   +13 more
doaj  

Everolimus-eluting coronary stents

Medical Devices: Evidence and Research, 2010
Alejandro Saez, Raul MorenoDivision of Interventional Cardiology, University Hospital La Paz, Madrid, SpainAbstract: Bare metal stents enabled a reduction in the risk of early procedural complications and restenosis in comparison with balloon angioplasty
Alejandro Saez, Raul Moreno
doaj  

Drug-eluting coronary stents – focus on improved patient outcomes

Patient Related Outcome Measures, 2011
Zehra Jaffery, Amit Prasad, John H Lee, Christopher J WhiteDepartment of Cardiovascular Diseases, The John Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation, New Orleans, LA, USAAbstract: The development of stent has been a major advance in
Jaffery Z, Prasad A, Lee JH, White CJ
doaj  

A Comprehensive Meta-Analysis of Bioadaptor Versus Drug-Eluting Stents in Randomised Trials With Exploratory Single-Arm Landmark Analyses. [PDF]

Eur J Clin Invest
Wölbert S, Kühne S, Patrignani A, Chiarito M, von Scheidt M, Torzewski J, Raake P, Bongiovanni D.   +7 more
europepmc   +1 more source

Improvements of Blood Compatibility, Drug-in-Polymer Coating Stability and Prevention of Crack Formation: Application to Drug-Eluting Stents. [PDF]

Pharmaceutics
Bedair TM, Han DK.
europepmc   +1 more source

Clinical efficacy of drug-eluting stents in the treatment of vertebral artery stenosis and analysis of factors contributing to stent restenosis. [PDF]

Front Neurol
Wei X, Ma Z, Wu H, Jiang H, Lan W, Xu L, Du M, Cao H, Wang X, Qiu F.   +9 more
europepmc   +1 more source

Outcomes of durable versus biodegradable polymer drug-eluting stents in patients with coronary artery disease. [PDF]

Int J Cardiol Heart Vasc
Skos C, Rogozarski J, Dizdarevic AM, M Steiner-Gager G, Postula M, Eyileten C, Toma A, Speidl WS, Skoro-Sajer N, Gerges C, Lang IM, Siller-Matula JM.   +11 more
europepmc   +1 more source

Consistency of primary outcomes in evidence synthesis researches on drug-eluting stents for coronary artery disease. [PDF]

BMC Med Res Methodol
Lin X, Tan S, Huang Y, Zhao J, Yao J, Han D, Luo R, Wu H, Sun S, Lan J, Zhang R, Zhao H, Hu L, Wang J, Zheng W, He R, Zhang J.   +16 more
europepmc   +1 more source